Beckman Coulter Inc. announced this afternoon that it will shutter a centrifuge development
and manufacturing facility in Palo Alto, Calif., and move its operations to Indianapolis. The Palo Alto facility employs 220
people.
Beckman Coulter, based in Fullerton, Calif., said the move will cut costs and improve its
ability to recruit and retain skilled employees.
“Closing our facility in Palo Alto was a difficult decision because the people there
have always done excellent work and we have a long history in the area,” Beckman Coulter senior vice president Pam Miller
said in a statement.
“By relocating our operations to the Indianapolis area, we can work aggressively to manage our costs and maintain our leadership position in centrifugation, an important asset of the company,” Miller’s statement continued. “Also, we’re able to take a longer-term view of workforce planning.”
“By relocating our operations to the Indianapolis area, we can work aggressively to manage our costs and maintain our leadership position in centrifugation, an important asset of the company,” Miller’s statement continued. “Also, we’re able to take a longer-term view of workforce planning.”
Beckman Coulter said several factors contributed to the decision. They included the presence
of an existing Beckman Coulter operation in Indianapolis; the area’s favorable business environment and low cost of
business; its central location and strong engineering and manufacturing workforce; and the state’s strategic focus on
life sciences and advanced manufacturing.
The company generates $2.4 billion in sales a year manufacturing biomedical testing systems.
Shares of Beckman Coulter are traded on the New York Stock Exchange under the symbol BEC.
on Facebook & Twitter
Back to Top
IBJ Conversations
0 Comments
Add Comment